KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Cash: 2010-2025

Historic Change in Cash for Arbutus Biopharma (ABUS) over the last 13 years, with Sep 2025 value amounting to -$15.0 million.

  • Arbutus Biopharma's Change in Cash rose 51.51% to -$15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 165.93%. This contributed to the annual value of $10.0 million for FY2024, which is 323.67% up from last year.
  • Arbutus Biopharma's Change in Cash amounted to -$15.0 million in Q3 2025, which was down 4,565.48% from $336,000 recorded in Q2 2025.
  • Over the past 5 years, Arbutus Biopharma's Change in Cash peaked at $46.9 million during Q3 2021, and registered a low of -$48.5 million during Q2 2021.
  • Moreover, its 3-year median value for Change in Cash was $746,000 (2025), whereas its average is -$760,727.
  • Within the past 5 years, the most significant YoY rise in Arbutus Biopharma's Change in Cash was 604.74% (2021), while the steepest drop was 348.77% (2021).
  • Arbutus Biopharma's Change in Cash (Quarterly) stood at $31.4 million in 2021, then crashed by 78.43% to $6.8 million in 2022, then rose by 29.27% to $8.8 million in 2023, then crashed by 48.78% to $4.5 million in 2024, then soared by 51.51% to -$15.0 million in 2025.
  • Its Change in Cash was -$15.0 million in Q3 2025, compared to $336,000 in Q2 2025 and $746,000 in Q1 2025.